In vitro efficacies of caspofungin or micafungin catheter lock solutions on Candida albicans biofilm growth.
@article{Cateau2008InVE, title={In vitro efficacies of caspofungin or micafungin catheter lock solutions on Candida albicans biofilm growth.}, author={Estelle Cateau and Marie-H{\'e}l{\`e}ne Rodier and Christine Imbert}, journal={The Journal of antimicrobial chemotherapy}, year={2008}, volume={62 1}, pages={ 153-5 } }
OBJECTIVES
Caspofungin and micafungin belong to the echinocandins; the mechanism of action of echinocandins is based on the inhibition of (1,3)-beta-D-glucan synthase. The aim of this study was to investigate in vitro the optimal antifungal lock treatment details against a Candida albicans biofilm.
METHODS
An in vitro model of a C. albicans (ATCC 3153 or ATCC 66396) biofilm associated with 100% silicone catheters was used. The effectiveness of the antifungal treatment was assayed against…
Figures from this paper
95 Citations
Possible role of azole and echinocandin lock solutions in the control of Candida biofilms associated with silicone.
- Biology, MedicineInternational journal of antimicrobial agents
- 2011
[Scientific evidence supporting the use of micafungin in the treatment of invasive candidiasis].
- Medicine, BiologyEnfermedades infecciosas y microbiologia clinica
- 2011
Cutibacterium acnes protects Candida albicans from the effect of micafungin in biofilms.
- BiologyInternational journal of antimicrobial agents
- 2018
Caspofungin: when and how? The microbiologist’s view
- Biology, MedicineMycoses
- 2012
Caspofungin represents a significant advance in the care of patients with serious fungal infections and is therefore favoured in patients with moderately severe to severe illness, recent azole exposure and in those who are at high risk of infections due to Candida glabrata or Candida krusei.
In vitro Susceptibilities of Iranian Clinical non-albicans Candida species to Caspofungin and Ketoconazole
- Medicine, Biology
- 2012
Caspofungin and Ketoconazole appear active against Iranian non-albicans candida isolates and in addition, a small percentage of isolates from patients with cancer, AIDS, diabetes and Bahjat showed a dose-dependent susceptibility to ketoconazoles.
Efficacy of anidulafungin in the treatment of experimental Candida parapsilosis catheter infection using an antifungal-lock technique.
- Medicine, BiologyThe Journal of antimicrobial chemotherapy
- 2016
Anidulafungin-lock therapy showed the highest activity for experimental catheter-related infection with C. parapsilosis and Silicone discs may be a more reliable substrate for the study of in vitro biofilm susceptibility.
Effect of antifungals on itraconazole resistant Candida glabrata
- BiologyCentral European Journal of Biology
- 2010
The results show that resistance of different C. glabrata strains is azole specific and therefore a single azole resistance cannot be assumed to indicate general azole Resistance, and low concentrations of these agents reduced biofilm formation as well.
Susceptibility of Candida glabrata biofilms to echinocandins: alterations in the matrix composition
- BiologyBiofouling
- 2018
The data suggest that, generally, after contact with echinocandins, the concentration of β-1,3 glucans increased, and adjustments in the matrix composition of C. glabrata biofilms seem responsible and may determine the effectivity of the drug responses.
Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis - review of the literature
- Medicine, BiologyEuropean journal of medical research
- 2011
All three echinocandins are highly effective if not superior to treatment with either fluconazole or Amphotericin B, particularly in well-defined clinical settings such as invasive Candida infections, Candida oesophagitis and candidaemia, and all three agents have an excellent safety profile.
Efficacy of liposomal amphotericin B and anidulafungin using an antifungal lock technique (ALT) for catheter-related Candida albicans and Candida glabrata infections in an experimental model
- Biology, MedicinePloS one
- 2019
In vitro susceptibility of liposomal amphotericin B and anidulafungin on Candida albicans and Candida glabrata biofilms growing on silicone discs was compared to find a promising antifungal lock technique for long-term catheter-related infections.
References
SHOWING 1-10 OF 11 REFERENCES
Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms.
- Medicine, BiologyThe Journal of antimicrobial chemotherapy
- 2005
It is demonstrated that caspofungin used at MIC was not sufficient to reduce C. albicans bio Films, but it suggested an activity on C. parapsilosis biofilms depending on their maturation age, and indicated that casingofungins used at 2 mg/L could be a good candidate in the prevention of candidiasis associated with silicone medical devices.
Caspofungin modulates in vitro adherence of Candida albicans to plastic coated with extracellular matrix proteins.
- Medicine, BiologyThe Journal of antimicrobial chemotherapy
- 2004
This study demonstrated the anti-adherent activity of caspofungin but indicated a reduced effect in the case of in vitro fluconazole resistance and indicated a possible relationship between the efficiency and the resistance of C. albicans to flu Conazole in vitro.
In vitro effects of micafungin against Candida biofilms on polystyrene and central venous catheter sections.
- Biology, MedicineInternational journal of antimicrobial agents
- 2006
Paradoxical Growth Effect of Caspofungin Observed on Biofilms and Planktonic Cells of Five Different Candida Species
- BiologyAntimicrobial Agents and Chemotherapy
- 2007
The accumulation of enlarged, globose cells was associated with PG, and it is hypothesized that CAS-induced changes in the cell wall composition may be the explanation.
The effect of aminocandin (HMR 3270) on the in-vitro adherence of Candida albicans to polystyrene surfaces coated with extracellular matrix proteins or fibronectin.
- Biology, MedicineClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
- 2007
The ability of aminocandin to inhibit the first step in the development of Candida albicans biofilms appeared to be independent of the in-vitro resistance of C.Albicans to fluconazole, and it was suggested that this activity was at least equivalent with flu Conazole-resistant strains.
Species-Specific Differences in the Susceptibilities of Biofilms Formed by Candida Bloodstream Isolates to Echinocandin Antifungals
- BiologyAntimicrobial Agents and Chemotherapy
- 2007
ABSTRACT The echinocandin susceptibilities of bloodstream Candida isolates growing in a biofilm was investigated. Within the therapeutic range of concentrations of each drug, caspofungin and…
Guidelines for the Management of Intravascular Catheter-Related Infections
- Medicine, BiologyInfection Control & Hospital Epidemiology
- 2001
These guidelines from the Infectious Diseases Society of America, the American College of Critical Care Medicine, and the Society for Healthcare Epidemiology of America contain recommendations for the management of adults and children with, and diagnosis of infections related to, peripheral and nontunneled central venous catheters, pulmonary artery catheter, tunneled central cathetes, and implantable devices.
The antibiotic-lock technique for therapy of 'highly needed' infected catheters.
- Medicine, BiologyClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
- 2002
Results of several open studies indicate that the antibiotic-lock technique may be regarded as an alternative to the conservative treatment of noncomplicated intraluminal catheter-related bacteremia, in which infection may be treated without catheter removal.
European Confederation of Medical Mycology (ECMM) prospective survey of candidaemia: report from one Italian region.
- Medicine, BiologyThe Journal of hospital infection
- 2002
An ECMM epidemiological prospective survey of candidaemia was performed in one Italian region by the National Society of Medical Mycology by the FIMUA from September 1997 to December 1999 and underscores the importance ofCandida albicans was identified in 58% of cases.